SOMAPACITAN-BECO: 47 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
47
Total FAERS Reports
5 (10.6%)
Deaths Reported
15
Hospitalizations
47
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities
Prescription
Status
FDA Application: 761156 ·
First Report: 20220101 · Latest Report: 20250901
What Are the Most Common SOMAPACITAN-BECO Side Effects?
#1 Most Reported
Seizure
3 reports (6.4%)
#2 Most Reported
Headache
3 reports (6.4%)
#3 Most Reported
Vomiting
2 reports (4.3%)
All SOMAPACITAN-BECO Side Effects by Frequency
No side effect data available.
Who Reports SOMAPACITAN-BECO Side Effects? Age & Gender Data
Gender: 57.1% female, 42.9% male. Average age: 34.4 years. Most reports from: JP. View detailed demographics →
Is SOMAPACITAN-BECO Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2022 | 2 | 1 | 1 |
| 2023 | 7 | 1 | 4 |
| 2024 | 16 | 2 | 4 |
| 2025 | 11 | 0 | 4 |
What Is SOMAPACITAN-BECO Used For?
| Indication | Reports |
|---|---|
| Growth hormone deficiency | 23 |
| Hypopituitarism | 8 |
| Product used for unknown indication | 8 |
Official FDA Label for SOMAPACITAN-BECO
Official prescribing information from the FDA-approved drug label.